ERBB2 and breast cancer: Proposed by Perou and colleagues in 2000, it divided BC into five molecular subtypes based on gene expression clustering of microarrays, each characterized by distinctive expression and growth rates of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor2 (HER2) [20].